Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma
Laura A Johnson, John Scholler, Takayuki Ohkuri, Akemi Kosaka, Prachi R Patel, Shannon E McGettigan, Arben Nace, Pramod Thekkat, Andreas Loew, Taylor J Chen, Joseph A Fraietta, Avery D Posey, Alina C Boesteanu, Alexandria P Cogdill, Boris Engels, Reshma Singh, Tucker R Ezell, Neeraja Idamakanti, Gabriela Plesa, John Seykora, Hideho Okada, Carl June, Jennifer Brogdon, Marcela Maus
Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) O1; DOI: 10.1186/2051-1426-2-S3-O1